Next Week in SHARP – August 2nd to 8th

Upcoming Presentations

August 5th – 4:00pm to 5:00pm – Presentation by Dr. Ko Un ‘Clara’ Park

“Implementation of New Commission on Cancer (CoC) Accreditation Surgical Standards”


Upcoming Events

The 2020 ATRN Health Summit is accepting abstracts for presentations and posters. The theme for the 2020 ATRN Health Summit is Community-Engaged Research in Translational Science: Innovations to Improve Health in Appalachia.

We are most interested in research, programs, and/or community efforts that highlight success in improving health and well-being in the Appalachian Region. The Summit will showcase both podium presentations and poster sessions. There is no cost for abstract submission. Abstracts are due August 7, 2020 at 11:59 PM. We encourage student attendance and abstract submission. Submit by clicking here.

We accept presentations and posters on a variety of themes focused around health topics, special populations, and methods and programs.

Some themes identified include:

• Health topics (e.g., COVID-19, substance use, behavioral health, tobacco use and vaping, nutrition and food deserts, chronic disease, cancer control, environmental health, and health inequities);
• Special populations (e.g., children and adolescents, older adults, women, LGBTQIA+ persons, immigrants and refugees, people of color, and historically marginalized communities); and
• Innovative methods aligned with community-engaged and translational research, particularly within the context of COVID-19.

Learn More

Submit Abstract


Funding Opportunities

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 – Clinical Trial Optional)

NIMHD is partnering with National Institute on Aging (NIA), National Institute on Drug Abuse (NIDA) and National Cancer Institute (NCI) to support a new funding opportunity announcement (FOA): PA-20-172. The FOA is titled: Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 – Clinical Trial Optional).

The purpose of this FOA is to support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters on health care systems serving health disparity populations across communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinas, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.

Application First Due Date: October 5, 2020.

For inquiries related to NIMHD’s scientific and research involvement concerning this FOA, contact Dr. Larissa Avilés-Santa at avilessantal@nih.gov. View the full funding opportunity announcement for more information.

For more information: https://grants.nih.gov/grants/guide/pa-files/PA-20-172.html?utm_medium=email&utm_source=govdelivery

 

 

NIH R01 Funding for COVID-19 Research

https://grants.nih.gov/grants/guide/pa-files/PAR-20-237.html

This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups.

 

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-119.html?utm_medium=email&utm_source=govdelivery

This Notice of Special Interest (NOSI) highlights the urgent need to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing among underserved and/or vulnerable populations across the United States through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities. The funding for this supplement is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

 

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-120.html?utm_medium=email&utm_source=govdelivery

Through its Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative, NIH aims to understand the factors that lead to COVID-19–related health disparities so that effective interventions can be implemented. As part of this initiative, NIMHD is supporting 2-year community-engaged Testing Research Projects. These projects will examine SARS-CoV-2 infection patterns and efforts to increase access and effectiveness of testing among underserved populations.

 

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-121.html?utm_medium=email&utm_source=govdelivery

This Notice of Special Interest (NOSI) highlights the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. These two-year community-engaged Testing Research Projects will examine SARS-CoV-2 infection patterns and efforts to increase access and effectiveness of diagnostic methods through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities. The funding for this supplement program is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

 

https://grants.nih.gov/grants/guide/pa-files/PAR-20-243.html

This Funding Opportunity Announcement (FOA) aims to support research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and future public health emergencies, including pandemics. While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this funding opportunity is to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations.

 

Additionally, the OSU Office of Research is collecting NIH and other agencies guidance here:  https://research.osu.edu/news-events/coronavirus-and-your-research-program/

 


Are you contemplating working with a unpaid summer/volunteer student?

SHARP can help you work out the logistics.  We can arrange for virtual access for OSU affiliates at no cost, and virtual access for non-OSU affiliates for a fee (to set up a virtual machine for them to remote to).

For more information, contact Judy M. Opalek, PhD (judy.opalek@osumc.edu)


SHARP Staff – Return to Campus

We are in the midst of our Return to Campus plan and you may be seeing us in the office more often. We need to adhere to the social distancing requirements in our shared space, and we will be working on modified schedules until a full return is feasible. All SHARP staff continue to be reachable by phone, email, and text, whether in the office or working remotely. We appreciate your patience during this time.

Please note that the SHARP staff are working 100% remotely at this time and are still fully available for virtual meetings and discussion.  We have nearly every normal tool at our disposal during this time and are only limited by face-to-face interactions and campus-based physical resources. If you have any questions or concerns—reach out!

 

Next Week in SHARP – July 26th to August 1st

Funding Opportunities

 

RE: Announcing a Request for Proposals (RFP) for COVID-19 Investigator Sponsored Research (ISR)

 

Dear Investigators,

 

At Bristol Myers Squibb, we understand that this is a difficult and busy time for all of our investigators as you work on the front lines dealing with the COVID-19 outbreak.  First and foremost, we want to let you know that BMS is focused on protecting our workforce’s health and safety, ensuring a continued supply of our medicines to patients and supporting relief efforts across the globe. BMS will take all necessary actions to promote public health and carry out our mission of providing life-saving medicines to patients who depend on us.

 

BMS is also committed to joining the broader academic and scientific community in the fight against COVID-19.   We continue to closely monitor the evolving situation across the globe, to this end, we would like to provide a few updates on how we are evolving our Investigator Sponsored Research (ISR) program related to COVID-19.

 

To ensure we are supporting the best scientific inquiries addressing the unmet needs of patients, BMS has decided to modify its COVID-19 ISR application process, changing from a rolling submission process to a time-period specific “Request for Proposal (RFP) process”. The RFP process will be published on BMS.com along with COVID-19 specific “Areas of Interest” on July 20th, 2020.  This will enable BMS to open a submission period from  the end of July  through August 15th, 2020 to begin accepting COVID-19 concept submissions. Our expectation is that we will receive a large number of proposals, leading to a very competitive process through which we will approve between 5-10 of the best scientific concepts, each with a budget of up to $2M.

·         The new process will be limited to COVID-19 concepts only.

·         Due to the alliance between Pfizer and BMS, COVID-19 concepts involving apixaban will continue with its existing review processes outside of this RFP.

·         All non COVID-19 proposals will continue their existing processes.

 

For further information, please contact your BMS Medical Representative or go to BMS.com for additional details.

 

As we share these timelines, I believe we can all appreciate that the ongoing pandemic has necessitated flexibility in the way we work. Thus, given the unpredictability of the ongoing COVID-19 pandemic, these timelines are subject to change.  As always, your local medical/field medical point will be the source of information should there be any questions or queries about changes to the ISR process.  Thank you in advance for your understanding and continued support during this period of transition.

 

Sincerely,

 

Paul Haluska MD, PhD

Vice President, Global Medical, Medical Data Generation

Bristol-Myers Squibb Company

 

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 – Clinical Trial Optional)

NIMHD is partnering with National Institute on Aging (NIA), National Institute on Drug Abuse (NIDA) and National Cancer Institute (NCI) to support a new funding opportunity announcement (FOA): PA-20-172. The FOA is titled: Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 – Clinical Trial Optional).

The purpose of this FOA is to support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters on health care systems serving health disparity populations across communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinas, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.

Application First Due Date: October 5, 2020.

For inquiries related to NIMHD’s scientific and research involvement concerning this FOA, contact Dr. Larissa Avilés-Santa at avilessantal@nih.gov. View the full funding opportunity announcement for more information.

For more information: https://grants.nih.gov/grants/guide/pa-files/PA-20-172.html?utm_medium=email&utm_source=govdelivery

 

NIH R01 Funding for COVID-19 Research

https://grants.nih.gov/grants/guide/pa-files/PAR-20-237.html

This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups.

 

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-119.html?utm_medium=email&utm_source=govdelivery

This Notice of Special Interest (NOSI) highlights the urgent need to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing among underserved and/or vulnerable populations across the United States through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities. The funding for this supplement is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

 

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-120.html?utm_medium=email&utm_source=govdelivery

Through its Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative, NIH aims to understand the factors that lead to COVID-19–related health disparities so that effective interventions can be implemented. As part of this initiative, NIMHD is supporting 2-year community-engaged Testing Research Projects. These projects will examine SARS-CoV-2 infection patterns and efforts to increase access and effectiveness of testing among underserved populations.

 

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-121.html?utm_medium=email&utm_source=govdelivery

This Notice of Special Interest (NOSI) highlights the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. These two-year community-engaged Testing Research Projects will examine SARS-CoV-2 infection patterns and efforts to increase access and effectiveness of diagnostic methods through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities. The funding for this supplement program is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

 

https://grants.nih.gov/grants/guide/pa-files/PAR-20-243.html

This Funding Opportunity Announcement (FOA) aims to support research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and future public health emergencies, including pandemics. While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this funding opportunity is to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations.

 

Additionally, the OSU Office of Research is collecting NIH and other agencies guidance here:  https://research.osu.edu/news-events/coronavirus-and-your-research-program/


Publications

Cultivating emergency physician behavioral empathy to improve emergency department care for pain and prescription opioid misuse by Maher Kazimi MBBS, MPH, Thomas Terndrup, MD, Raymond Tait, PhD, Jennifer A. Frey PhD, CCRP, Scott Strassels PharmD, PhD, Geremiah Emerson MD, Knox H. Todd MD, MPH.


Are you contemplating working with a unpaid summer/volunteer student?

SHARP can help you work out the logistics.  We can arrange for virtual access for OSU affiliates at no cost, and virtual access for non-OSU affiliates for a fee (to set up a virtual machine for them to remote to).

For more information, contact Judy M. Opalek, PhD (judy.opalek@osumc.edu)


SHARP Summer Break

Our SHARP weekly meetings are taking a summer break from June 24th to August 5th. We will see you again on August 12th!

SHARP Staff – Return to Campus

We are in the midst of our Return to Campus plan and you may be seeing us in the office more often. We need to adhere to the social distancing requirements in our shared space, and we will be working on modified schedules until a full return is feasible. All SHARP staff continue to be reachable by phone, email, and text, whether in the office or working remotely. We appreciate your patience during this time.

Please note that the SHARP staff are working 100% remotely at this time and are still fully available for virtual meetings and discussion.  We have nearly every normal tool at our disposal during this time and are only limited by face-to-face interactions and campus-based physical resources. If you have any questions or concerns—reach out!

 

Next Week in SHARP – July 12th to 18th

Funding Opportunities

 

Request for Proposals

Basic/Translational or Clinical Research
Effects of SARS-CoV-2 Coronavirus on Surgical Patients or Practice

Application Deadline: July 15, 2020

Date of Award: August 1, 2020

Amount of Award: USD 30,000.00

The Surgical Infection Society (SIS) is dedicated to the understanding, prevention, and management of surgical infections. The coronavirus pandemic had an unprecedented impact upon surgical patients and practice that is still being defined. Recognizing these circumstances, the SIS Foundation for Education and Research announces a special Request for Proposals (RFP) for basic/translational or clinical research into the impact of SARS-CoV-2 on the surgical team, surgical patients, or surgical practice.

Interested applicants should submit a proposal of not more than six pages plus an NIH-style curriculum vitae and budget to Lynn J. Hydo, MBA, Executive Director (lhydo@aol.com) on or before July 15, 2020. Inclusion of preliminary data is encouraged. Applications should reflect relevant multidisciplinary collaboration (e.g., cell biologists, epidemiologists, immunologists, virologists, etc..) depending on the nature of the proposal. Evidence of additional/matching funding for the project will receive favorable consideration. Applications will be adjudicated by the Board of Trustees of the Foundation. Indirect costs will not be awarded per the policy of the Foundation.

The successful applicant will be required to provide a 30-minute SIS Virtual Grand Rounds presentation via webinar on a topic related to the research proposal, and agree that a video recording of the presentation will be made available on the SIS website.

Surgical Infection Society
PO Box 1278, East Northport, NY 11731
www.sisna.org | 1-631-368-1880

 

 

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 – Clinical Trial Optional)

NIMHD is partnering with National Institute on Aging (NIA), National Institute on Drug Abuse (NIDA) and National Cancer Institute (NCI) to support a new funding opportunity announcement (FOA): PA-20-172. The FOA is titled: Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 – Clinical Trial Optional).

The purpose of this FOA is to support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters on health care systems serving health disparity populations across communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinas, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.

Application First Due Date: October 5, 2020.

For inquiries related to NIMHD’s scientific and research involvement concerning this FOA, contact Dr. Larissa Avilés-Santa at avilessantal@nih.gov. View the full funding opportunity announcement for more information.

For more information: https://grants.nih.gov/grants/guide/pa-files/PA-20-172.html?utm_medium=email&utm_source=govdelivery

 

NIH R01 Funding for COVID-19 Research

https://grants.nih.gov/grants/guide/pa-files/PAR-20-237.html

This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups.

 

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-119.html?utm_medium=email&utm_source=govdelivery

This Notice of Special Interest (NOSI) highlights the urgent need to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing among underserved and/or vulnerable populations across the United States through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities. The funding for this supplement is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

 

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-120.html?utm_medium=email&utm_source=govdelivery

Through its Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative, NIH aims to understand the factors that lead to COVID-19–related health disparities so that effective interventions can be implemented. As part of this initiative, NIMHD is supporting 2-year community-engaged Testing Research Projects. These projects will examine SARS-CoV-2 infection patterns and efforts to increase access and effectiveness of testing among underserved populations.

 

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-121.html?utm_medium=email&utm_source=govdelivery

This Notice of Special Interest (NOSI) highlights the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. These two-year community-engaged Testing Research Projects will examine SARS-CoV-2 infection patterns and efforts to increase access and effectiveness of diagnostic methods through the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative. The overarching goal is to understand factors that have led to disproportionate burden of the pandemic on these underserved populations so that interventions can be implemented to decrease these disparities. The funding for this supplement program is provided from the Paycheck Protection Program and Health Care Enhancement Act, 2020.

 

https://grants.nih.gov/grants/guide/pa-files/PAR-20-243.html

This Funding Opportunity Announcement (FOA) aims to support research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and future public health emergencies, including pandemics. While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this funding opportunity is to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations.

 

Additionally, the OSU Office of Research is collecting NIH and other agencies guidance here:  https://research.osu.edu/news-events/coronavirus-and-your-research-program/


Publications

Cultivating emergency physician behavioral empathy to improve emergency department care for pain and prescription opioid misuse by Maher Kazimi MBBS, MPH, Thomas Terndrup, MD, Raymond Tait, PhD, Jennifer A. Frey PhD, CCRP, Scott Strassels PharmD, PhD, Geremiah Emerson MD, Knox H. Todd MD, MPH.


Are you contemplating working with a unpaid summer/volunteer student?

SHARP can help you work out the logistics.  We can arrange for virtual access for OSU affiliates at no cost, and virtual access for non-OSU affiliates for a fee (to set up a virtual machine for them to remote to).

For more information, contact Judy M. Opalek, PhD (judy.opalek@osumc.edu)


SHARP Summer Break

Our SHARP weekly meetings are taking a summer break from June 24th to August 5th. We will see you again on August 12th!

SHARP Staff – Return to Campus

We are in the midst of our Return to Campus plan and you may be seeing us in the office more often. We need to adhere to the social distancing requirements in our shared space, and we will be working on modified schedules until a full return is feasible. All SHARP staff continue to be reachable by phone, email, and text, whether in the office or working remotely. We appreciate your patience during this time.

Please note that the SHARP staff are working 100% remotely at this time and are still fully available for virtual meetings and discussion.  We have nearly every normal tool at our disposal during this time and are only limited by face-to-face interactions and campus-based physical resources. If you have any questions or concerns—reach out!

 

Log in